Flagship explainer
How Ocular Therapeutix, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $52M | 100% |
| |
| Cost of revenue | $6.6M | 13% |
|
| $45.4M | 87% |
| |
| −$270M | −520% |
| |
| Income before tax | −$266M | −512% |
|
| Income tax | $0 | 0% |
|
| −$266M | −512% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001104659-26-010664